NeoGenomics (FRA:NG9) Cyclically Adjusted Book per Share: €5.57 (As of Mar. 2026)


FRA:NG9 NeoGenomics Inc FRA:NG9
72 GF Score
Price €12.72
GF Value €14.99
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is NeoGenomics Cyclically Adjusted Book per Share?

NeoGenomics FRA:NG9 +3.04% 72 Cyclically Adjusted Book per Share is €5.57 as of Mar. 2026. GuruFocus rates FRA:NG9 with a GF Score™ of 72/100 and a GF Value™ of €14.99 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

NeoGenomics's adjusted book value per share for the three months ended in Mar. 2026 was €5.529. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.57 for the trailing ten years ended in Mar. 2026.

During the past 12 months, NeoGenomics's average Cyclically Adjusted Book Growth Rate was 9.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 23.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of NeoGenomics was 75.00% per year. The lowest was 15.40% per year. And the median was 40.95% per year.

As of today (2026-07-11), NeoGenomics's current stock price is €12.715. NeoGenomics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €5.57. NeoGenomics's Cyclically Adjusted PB Ratio of today is 2.28.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of NeoGenomics was 28.25. The lowest was 0.84. And the median was 11.38.


NeoGenomics  (FRA:NG9) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

NeoGenomics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.715/5.57
=2.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of NeoGenomics was 28.25. The lowest was 0.84. And the median was 11.38.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


NeoGenomics Cyclically Adjusted Book per Share Related Terms


NeoGenomics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for NeoGenomics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics Cyclically Adjusted Book per Share Chart

NeoGenomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.66 3.92 4.72 5.55 5.63

NeoGenomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.54 5.13 5.28 5.63 5.57

FRA:NG9 vs WGS, CDNA, PSNL: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, NeoGenomics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoGenomics Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NeoGenomics's Cyclically Adjusted PB Ratio falls into.


FRA:NG9
72GF Score
NeoGenomics Inc FRA:NG9
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeoGenomics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeoGenomics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.529/330.2130*330.2130
=5.529

Current CPI (Mar. 2026) = 330.2130.

NeoGenomics Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.327 241.018 3.188
201609 2.279 241.428 3.117
201612 1.975 241.432 2.701
201703 1.990 243.801 2.695
201706 1.895 244.955 2.555
201709 1.770 246.819 2.368
201712 1.806 246.524 2.419
201803 1.737 249.554 2.298
201806 1.722 251.989 2.257
201809 2.798 252.439 3.660
201812 2.982 251.233 3.919
201903 3.007 254.202 3.906
201906 4.174 256.143 5.381
201909 4.333 256.759 5.573
201912 4.358 256.974 5.600
202003 4.337 258.115 5.548
202006 5.262 257.797 6.740
202009 5.096 260.280 6.465
202012 5.092 260.474 6.455
202103 6.050 264.877 7.542
202106 7.767 271.696 9.440
202109 7.845 274.310 9.444
202112 7.903 278.802 9.360
202203 7.826 287.504 8.989
202206 7.855 296.311 8.754
202209 8.084 296.808 8.994
202212 7.423 296.797 8.259
202303 7.155 301.836 7.828
202306 6.941 305.109 7.512
202309 6.976 307.789 7.484
202312 6.779 306.746 7.298
202403 6.666 312.332 7.048
202406 6.655 314.175 6.995
202409 6.390 315.301 6.692
202412 6.725 315.605 7.036
202503 6.401 319.799 6.609
202506 5.754 322.561 5.891
202509 5.542 324.800 5.634
202512 5.539 324.054 5.644
202603 5.529 330.213 5.529

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €5.57 mean?
NeoGenomics (FRA:NG9) has a Cyclically Adjusted Book per Share of €5.57 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NeoGenomics and its competitors.
Is NeoGenomics' Cyclically Adjusted Book per Share too high?
NeoGenomics' current Cyclically Adjusted Book per Share is €5.57. Overall, NeoGenomics has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NeoGenomics' Cyclically Adjusted Book per Share compare to WGS and CDNA?
NeoGenomics' Cyclically Adjusted Book per Share of €5.57 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NeoGenomics and its competitors. NeoGenomics's current Cyclically Adjusted Book per Share is €5.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoGenomics stock overvalued right now?
Based on GuruFocus' analysis, NeoGenomics (FRA:NG9) is currently considered Fairly Valued. The stock's GF Value™ is €14.99, compared to a current price of €12.72 — trading 15.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is €5.57. NeoGenomics' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For NeoGenomics (FRA:NG9), the current Cyclically Adjusted Book per Share is €5.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (FRA:NG9) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of €12.72 is trading 15.2% below its estimated GF Value™ of €14.99. GuruFocus considers NeoGenomics to be Fairly Valued.

Key valuation signals for FRA:NG9:

  • Cyclically Adjusted Book per Share: €5.57
  • GF Value™: €14.99 vs. price of €12.72 (15.2% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the FRA:NG9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NeoGenomics Business Description

Other Exchanges NEO:USANEO:Mexico
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
72GF Score

Get the complete analysis for FRA:NG9

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.72
Price
€14.99
GF Value